TCM
ELEV
TCG Crossover Management’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-288,390
| Closed | -$274K | – | 23 |
|
|
2022
Q4 | $274K | Sell |
288,390
-266,610
| -48% | -$253K | 0.05% | 21 |
|
|
2022
Q3 | $627K | Hold |
555,000
| – | – | 0.19% | 21 |
|
|
2022
Q2 | $777K | Hold |
555,000
| – | – | 0.33% | 21 |
|
|
2022
Q1 | $1.4M | Hold |
555,000
| – | – | 0.56% | 20 |
|
|
2021
Q4 | $3.34M | Buy |
+555,000
| New | +$3.34M | 1.56% | 15 |
|